Zomedica Corp. Quarterly Operating Income (Loss) in USD from Q1 2017 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Zomedica Corp. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2017 to Q2 2024.
Zomedica Corp. Operating Income (Loss) for the quarter ending June 30, 2024 was -$25.1M, a 272% decline year-over-year.
Zomedica Corp. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$28.7M, a 10.5% decline year-over-year.
Zomedica Corp. annual Operating Income (Loss) for 2023 was -$7.51M, a 65.7% increase from 2022.
Zomedica Corp. annual Operating Income (Loss) for 2022 was -$21.9M, a 2.57% decline from 2021.
Zomedica Corp. annual Operating Income (Loss) for 2021 was -$21.4M, a 27.5% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	-$28.7M	-$25.1M	-$18.3M	-272%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-14
Q1 2024	-$10.4M	-$10.4M	-$2.87M	-38.3%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	-$7.51M	$12.7M	+$17.8M		Oct 1, 2023	Dec 31, 2023	10-Q	2024-05-09
Q3 2023	-$25.3M	-$5.95M	+$644K	+9.77%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-13
Q2 2023	-$26M	-$6.74M	-$862K	-14.7%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-14
Q1 2023	-$25.1M	-$7.51M	-$3.2M	-74.1%	Jan 1, 2023	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	-$21.9M	-$5.14M	+$628K	+10.9%	Oct 1, 2022	Dec 31, 2022	10-K	2024-04-01
Q3 2022	-$22.6M	-$6.59M	-$184K	-2.87%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-13
Q2 2022	-$22.4M	-$5.88M	-$551K	-10.3%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-10
Q1 2022	-$21.8M	-$4.31M	-$442K	-11.4%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-11
Q4 2021	-$21.4M	-$5.77M	-$1.64M	-39.6%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-15
Q3 2021	-$19.7M	-$6.41M	-$1.41M	-28.1%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-14
Q2 2021	-$18.3M	-$5.33M	-$26.5K	-0.5%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-15
Q1 2021	-$18.3M	-$3.87M	-$1.54M	-65.9%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-10
Q4 2020	-$16.8M	-$4.13M	-$1.27M	-44.5%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-01
Q3 2020	-$15.5M	-$5M	-$2.16M	-75.8%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-12
Q2 2020	-$13.3M	-$5.3M	-$2.91M	-122%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-11
Q1 2020	-$10.4M	-$2.33M	+$9.36M	+80%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-12
Q4 2019	-$19.8M	-$2.86M	+$5.56M	+66.1%	Oct 1, 2019	Dec 31, 2019	10-K	2021-02-26
Q3 2019	-$25.3M	-$2.84M	-$999K	-54.2%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-12
Q2 2019	-$24.3M	-$2.39M	+$1.76M	+42.4%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-10
Q1 2019	-$26.1M	-$11.7M	-$9.52M	-439%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-11
Q4 2018	-$16.6M	-$8.42M	-$5.86M	-229%	Oct 1, 2018	Dec 31, 2018	10-K	2020-02-26
Q3 2018	-$10.7M	-$1.85M	+$241K	+11.6%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-12
Q2 2018	-$11M	-$4.15M	-$2.56M	-161%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-08
Q1 2018	-$8.41M	-$2.17M	-$324K	-17.5%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-10
Q4 2017	-$8.08M	-$2.56M			Oct 1, 2017	Dec 31, 2017	10-K/A	2019-03-14
Q3 2017		-$2.09M			Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-13
Q2 2017		-$1.59M			Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-09
Q1 2017		-$1.85M			Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-15

* An asterisk sign (*) next to the value indicates that the value is likely invalid.